id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-331830-vr2eqsbq	Sawalha, Khalid	Systematic Review of COVID-19 Related Myocarditis: Insights on Management and Outcome	2020-08-18		.txt	text/plain	2828	171	49	Methods Using a combination of search terms in the PubMed/Medline, Ovid Medline and the Cochrane Library databases and manual searches on Google Scholar and the bibliographies of articles identified, we reviewed all cases reported in the English language citing myocarditis associated with COVID-19 infection. Results Fourteen records comprising a total of fourteen cases that report myocarditis/myopericarditis secondary to COVID-19 infection were identified. Infection with the novel pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also referred to as COVID-19, was first reported in Wuhan, China in December 2019 and declared a pandemic by the World Health Organization (WHO) in March 2020 (1). Pulmonary involvement is the most dominant clinical manifestation of COVID-19 including acute respiratory distress syndrome (ARDS) which is associated with higher mortality, up to 52.4% in one series (3). Until prospective studies and trials establish guidelines for the management of COVID-19 myocarditis, treatment has to be catered to individual case presentations.	./cache/cord-331830-vr2eqsbq.txt	./txt/cord-331830-vr2eqsbq.txt